Literature DB >> 15727747

[Five-year follow-up of urinary incontinence in older people in a Spanish rural population].

F Gavira Iglesias1, J M Caridad Y Ocerín, J B Guerrero Muñoz, M López Pérez, M Romero López, M V Pavón Aranguren.   

Abstract

OBJECTIVE: To determine prevalence, incidence and remission rates and change patterns of urinary incontinence (UI) over a 5-year time span.
DESIGN: Longitudinal study. LOCATION: Basic Health Zone of Cabra (Cordoba). PATIENTS: A random age-stratified sample of 827 subjects selected from a total of 5139 persons > or = 65 years of age and followed up between 1996 and 2001.
INTERVENTIONS: Home interview. MEASUREMENTS: Questions about detection and level of severity of UI, sociodemographic data, and level of functioning. Two logistic regression models were created to identify risk factors for the probability to be alive and to develop UI, respectively.
RESULTS: UI prevalence reached 36% at baseline and 46% five years later. Mortality rates were similar in continent and incontinent subjects. 54.5% of continent subjects in 1996 remained so in 2001. Five-year incidence and remission rates were 29% and 15%, respectively. In both sexes, slight and moderate incontinence mainly progressed to moderate and severe degrees, whereas severe UI remained unchanged in 40.1%. The main risk factors for increased survival and for UI incidence were self-rated health and level of functioning.
CONCLUSIONS: Prevalence of UI is high, incidence is moderate and remission is low. Urinary incontinence is a dynamic problem and does not affect mortality. Impaired mobility has a strong influence on UI incidence.

Entities:  

Mesh:

Year:  2005        PMID: 15727747

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  1 in total

Review 1.  Urinary Incontinence as a Predictor of Death: A Systematic Review and Meta-Analysis.

Authors:  Gregor John; Claire Bardini; Christophe Combescure; Patrick Dällenbach
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.